224 related articles for article (PubMed ID: 19540359)
1. Translational nanomedicine: status assessment and opportunities.
Murday JS; Siegel RW; Stein J; Wright JF
Nanomedicine; 2009 Sep; 5(3):251-73. PubMed ID: 19540359
[TBL] [Abstract][Full Text] [Related]
2. Challenges of clinical translation in nanomedicine: A qualitative study.
Satalkar P; Elger BS; Hunziker P; Shaw D
Nanomedicine; 2016 May; 12(4):893-900. PubMed ID: 26772431
[TBL] [Abstract][Full Text] [Related]
3. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
Milane L; Amiji M
Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
[TBL] [Abstract][Full Text] [Related]
4. Emerging nanomedicine applications and manufacturing: progress and challenges.
Sartain F; Greco F; Hill K; Rannard S; Owen A
Nanomedicine (Lond); 2016 Mar; 11(6):577-80. PubMed ID: 26911307
[TBL] [Abstract][Full Text] [Related]
5. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
Elder JB; Liu CY; Apuzzo ML
Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
[TBL] [Abstract][Full Text] [Related]
6. Changing the mindset in life sciences toward translation: a consensus.
Duda GN; Grainger DW; Frisk ML; Bruckner-Tuderman L; Carr A; Dirnagl U; Einhäupl KM; Gottschalk S; Gruskin E; Huber C; June CH; Mooney DJ; Rietschel ET; Schütte G; Seeger W; Stevens MM; Urban R; Veldman A; Wess G; Volk HD
Sci Transl Med; 2014 Nov; 6(264):264cm12. PubMed ID: 25429054
[TBL] [Abstract][Full Text] [Related]
7. Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines.
Rösslein M; Liptrott NJ; Owen A; Boisseau P; Wick P; Herrmann IK
Nanotoxicology; 2017 Mar; 11(2):147-149. PubMed ID: 28055261
[TBL] [Abstract][Full Text] [Related]
8. Cancer nanomedicine: from drug delivery to imaging.
Chow EK; Ho D
Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161
[TBL] [Abstract][Full Text] [Related]
9. The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine.
Bayda S; Adeel M; Tuccinardi T; Cordani M; Rizzolio F
Molecules; 2019 Dec; 25(1):. PubMed ID: 31892180
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles in modern medicine: state of the art and future challenges.
Murthy SK
Int J Nanomedicine; 2007; 2(2):129-41. PubMed ID: 17722542
[TBL] [Abstract][Full Text] [Related]
11. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
12. Nano/Microscale motors: biomedical opportunities and challenges.
Wang J; Gao W
ACS Nano; 2012 Jul; 6(7):5745-51. PubMed ID: 22770233
[TBL] [Abstract][Full Text] [Related]
13. Basic and clinical proteomics from the EU Health Research perspective.
Dyląg T; Jehenson P; van de Loo JW; Sanne JL
Proteomics Clin Appl; 2010 Dec; 4(12):888-91. PubMed ID: 21179890
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine: reshaping clinical practice.
Fadeel B; Kasemo B; Malmsten M; Strømme M
J Intern Med; 2010 Jan; 267(1):2-8. PubMed ID: 20059640
[No Abstract] [Full Text] [Related]
15. From bench to bedside: successful translational nanomedicine: highlights of the Third Annual Meeting of the American Academy of Nanomedicine.
Wei C; Liu N; Xu P; Heller M; Tomalia DA; Haynie DT; Chang EH; Wang K; Lee YS; Lyubchenko YL; Bawa R; Tian R; Hanes J; Pun S; Meiners JC; Guo P
Nanomedicine; 2007 Dec; 3(4):322-31. PubMed ID: 18068093
[TBL] [Abstract][Full Text] [Related]
16. Converging micro-nano-bio technologies towards integrated biomedical systems: state of the art and future perspectives under the EU-information & communication technologies program.
Lymberis A
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():6-8. PubMed ID: 19162579
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A
Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707
[TBL] [Abstract][Full Text] [Related]
18. Environmental air toxics: role in asthma occurrence?
Larsen GL; Beskid C; Shirnamé-Moré L
Environ Health Perspect; 2002 Aug; 110 Suppl 4(Suppl 4):501-4. PubMed ID: 12194880
[TBL] [Abstract][Full Text] [Related]
19. Translational Medicine is developing in China: a new venue for collaboration.
Wang X; Wang E; Marincola FM
J Transl Med; 2011 Jan; 9():3. PubMed ID: 21205297
[TBL] [Abstract][Full Text] [Related]
20. Nanotherapeutics in the EU: an overview on current state and future directions.
Hafner A; Lovrić J; Lakoš GP; Pepić I
Int J Nanomedicine; 2014; 9():1005-23. PubMed ID: 24600222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
